Xuzhou Xiaodong Cardiovascular Hospital is named after Academician Zhu Xiaodong, former Director of the Cardiovascular Disease Research Institute of the Chinese Academy of Medical Sciences and President of Fuwai Cardiovascular Hospital. Focusing on cardiac surgical treatment and aiming at the clinical application of the "artificial heart", the hospital strives to build a first-class cardiovascular specialty hospital in China. The hospital is located at No. 121 Xiadan Road, Xuzhou City, and is scheduled to open and operate in July 2019.
I. Technical Advantages and Features of the Hospital
1. Fuwai expert team: A cardiac surgery treatment team led by Lü Feng (Chief Physician of Fuwai Hospital, Professor, Doctor of Medicine, Director of the 27B Ward of the Department of Cardiac Surgery). A "artificial heart" advanced heart failure treatment team led by Li Guorong (Postdoctoral Fellow in Medicine, Professor, Researcher, Master's Supervisor, inventor of the fourth-generation artificial heart).
2. Artificial heart: At present, under the guidance of Academician Zhu Xiaodong of the Chinese Academy of Engineering, Li Guorong, China's first postdoctoral fellow in artificial hearts, and his research team have developed a fourth-generation "artificial heart" prototype. This achievement surpasses similar technical standards in Europe and the United States, reaches the ** level, and has completely independent intellectual property rights. It has now entered the clinical trial stage, and its implementation as soon as possible can bring hope for the rehabilitation of patients with advanced heart failure in China and *broad.
3. Integrated hybrid operating room for cardiac surgery: Taking the lead in the Huaihai Economic Zone, ** integrated hybrid operating rooms for cardiac surgery have been built, which can simultaneously perform imaging examinations and conventional cardiac surgery and vascular interventional implantation procedures. There is no need to transfer patients multiple times between the interventional treatment department and the operating room. For coronary heart disease with multivessel disease, complex congenital heart disease, complex aneurysms, multiple vascular lesions, etc., it is a very good treatment method, and it provides a new treatment strategy for avoiding the risks that may be brought by multiple anesthesia and transfers of patients, especially for high-risk patients who cannot tolerate traditional surgery.
II. Business Content Key projects: repair of intrathoracic great vessel injury, aortic aneurysm surgery, correction surgery for complete transposition of the great arteries, heart multi-valve replacement and plasty surgery, coronary artery bypass grafting surgery, heart bypass surgery, congenital heart disease surgery, valve replacement surgery; cardiac intervention, non-invasive or minimally invasive surgery such as coronary catheterization for acute myocardial infarction, cardiovascular stent angioplasty; pacemaker implantation; radiofrequency ablation for arrhythmia; repair of congenital heart disease defects; cardiac surgery with severe complications, artificial heart implantation surgery, etc.
What does Jingfu Cardiovascular Hospital (Xuzhou) Co., Ltd. require? Who is Xuzhou Jingfu Cardiovascular Hospital hiring? Xuzhou Jingfu Cardiovascular Hospital recruitment: 医疗卫生/美容保健类占比最多占100%,其次是经营管理类占8.7%. What education can get in at Xuzhou Jingfu Cardiovascular Hospital? 本科占比最多占91.3%,其次是不限占8.7%. Work experience required at Xuzhou Jingfu Cardiovascular Hospital? 1-3年占比最多占34.8%,其次是不限占26.1%. Where are the job locations at Xuzhou Jingfu Cardiovascular Hospital? 徐州占比最多占100%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows